Results 241 to 250 of about 273,871 (338)
Expression of concern "circ_0020123 promotes cell proliferation and migration in lung adenocarcinoma via PDZD8". [PDF]
Editors of Open Medicine.
europepmc +1 more source
This study aimed to investigate survival outcomes, the efficacy of lymph node (LN) dissection, and recurrence patterns in 69 patients who underwent R0 salvage surgery for esophageal squamous cell carcinoma. Of note, abdominal LN metastases had a negative impact on survival in our series.
Kotaro Sugawara+9 more
wiley +1 more source
Peritumoral features for assessing invasiveness of lung adenocarcinoma manifesting as ground-glass nodules. [PDF]
Wang X+5 more
europepmc +1 more source
Pathogen‐derived extracellular vesicle detection: theoretical insights and advanced methodologies: This review explores the theoretical foundations and practical applications of pEV detection, emphasizing the challenges and innovative strategies involving novel aggregate materials and machine learning for enhanced diagnostic accuracy.
Lihan Lai+6 more
wiley +1 more source
Comprehensive analysis indicates DDX46 as a novel biomarker for the prognosis of lung adenocarcinoma. [PDF]
Bian T+6 more
europepmc +1 more source
Development and Application of Organic Sonosensitizers in Cancer Therapy
This review provides a comprehensive overview of organic sonosensitizers employed in cancer treatment, describing their underlying mechanisms and structure‐activity relationship in terms of sonodynamic therapy. The significance of nanotechnology and combination therapy with other oncological modalities (photothermal therapy, photodynamic therapy, etc.)
Yuhan Ding+5 more
wiley +1 more source
PAR2 promotes malignancy in lung adenocarcinoma. [PDF]
Wang B+10 more
europepmc +1 more source
iPRISM: Intelligent Predicting Response to Cancer Immunotherapy through Systematic Modeling
The Intelligent Predicting Response to cancer Immunotherapy through Systematic Modeling (iPRISM) model uses data from genes and immune responses to predict how well cancer patients will respond to immunotherapy. Tested on multiple cancer types, iPRISM shows higher accuracy compared to existing methods.
Yinchun Su+7 more
wiley +1 more source